Balyasny Asset Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $1.01M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $16.4M | Sell |
|
|||||
|
2023
Q4 | $22.5M | Buy |
|
|||||
|
2023
Q3 | $6.4M | Buy |
|
|||||
|
2023
Q2 | $15.9M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $38.7K | Sell |
|
|||||
|
2022
Q3 | $430K | Buy |
|
|||||
|
2022
Q2 | $255K | Buy |
|
|||||
|
2022
Q1 | $114K | Buy |
|
|||||
|
2021
Q4 | $91K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $318K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.83M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $361K | Sell |
|
|||||
|
2018
Q2 | $1.48M | Buy |
|